4',6-dihydroxyflavone has been researched along with syringetin in 2 studies
| Studies (4',6-dihydroxyflavone) | Trials (4',6-dihydroxyflavone) | Recent Studies (post-2010) (4',6-dihydroxyflavone) | Studies (syringetin) | Trials (syringetin) | Recent Studies (post-2010) (syringetin) |
|---|---|---|---|---|---|
| 10 | 0 | 3 | 13 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
| Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
1 review(s) available for 4',6-dihydroxyflavone and syringetin
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
1 other study(ies) available for 4',6-dihydroxyflavone and syringetin
| Article | Year |
|---|---|
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |